Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Sustiva (efavirenz)-Important Communication from Bristol-Myers Squibb on the discontinuation of 100mg hard capsules
Notice type:
3rd Party Publications
Date:
23/01/2009
Problem Or Issue:
Please find therewith the healthare professional communication from Bristol-Myers Squibb concerning discontinuation of Sustiva 100mg hard capsules.
Healthcare Professional Communication-Sustiva 100mg hard capsules
« Back
Date Printed: 05/05/2024